Price T Rowe Associates Inc Amgen Inc Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,037,579 shares of AMGN stock, worth $567 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,037,579
Previous 2,643,117 22.91%
Holding current value
$567 Million
Previous $689 Million 7.85%
% of portfolio
0.08%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$258.59 - $327.36 $157 Million - $198 Million
-605,538 Reduced 22.91%
2,037,579 $635 Million
Q4 2024

Feb 14, 2025
SELL
$258.78 - $328.31 $493 Million - $625 Million
-1,903,289 Reduced 41.86%
2,643,117 $689 Million
Q3 2024

Nov 14, 2024
BUY
$309.38 - $337.38 $7.67 Million - $8.36 Million
24,792 Added 0.55%
4,546,406 $1.46 Billion
Q2 2024

Aug 14, 2024
BUY
$262.75 - $319.31 $364 Million - $442 Million
1,384,123 Added 44.12%
4,521,614 $1.41 Billion
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $921 Million - $1.11 Billion
-3,427,219 Reduced 52.21%
3,137,491 $892 Million
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $62.3 Million - $70.3 Million
243,720 Added 3.86%
6,564,710 $1.89 Billion
Q3 2023

Nov 14, 2023
BUY
$218.65 - $271.46 $324 Million - $402 Million
1,480,001 Added 30.57%
6,320,990 $1.7 Billion
Q2 2023

Aug 14, 2023
BUY
$214.27 - $253.37 $218 Million - $258 Million
1,018,577 Added 26.65%
4,840,989 $1.07 Billion
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $197 Million - $240 Million
872,399 Added 29.57%
3,822,412 $924 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $414 Million - $526 Million
1,806,456 Added 157.97%
2,950,013 $775 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $164 Million - $185 Million
-730,736 Reduced 38.99%
1,143,557 $258 Million
Q2 2022

Aug 15, 2022
SELL
$230.71 - $256.74 $182 Million - $202 Million
-788,648 Reduced 29.62%
1,874,293 $456 Million
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $1.23 Million - $1.36 Million
-5,595 Reduced 0.21%
2,662,941 $644 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $9.38 Million - $10.7 Million
47,146 Added 1.8%
2,668,536 $600 Million
Q3 2021

Nov 15, 2021
SELL
$212.27 - $248.7 $21.2 Million - $24.9 Million
-99,938 Reduced 3.67%
2,621,390 $557 Million
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $31.5 Million - $35 Million
-135,011 Reduced 4.73%
2,721,328 $663 Million
Q1 2021

May 17, 2021
SELL
$221.91 - $258.6 $45.3 Million - $52.8 Million
-204,010 Reduced 6.67%
2,856,339 $711 Million
Q4 2020

Feb 16, 2021
BUY
$216.38 - $257.67 $662 Million - $789 Million
3,060,349 New
3,060,349 $704 Million

Others Institutions Holding AMGN

# of Institutions
3,308
Shares Held
429M
Call Options Held
8.06M
Put Options Held
7.7M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email